A “maturity curve” can help organizations move engagement beyond performative gestures to a strategic asset.
Donna R. Cryer, J.D.
Advertisement
Donna R. Cryer, J.D., is a co-founder of CryerHealth, a boutique consulting firm, and a pioneer in the science of patient engagement. CryerHealth has advised dozens of corporate, governmental and charitable organizations. Driven by her own journey through pediatric IBD and liver transplantation, Donna is also the Founder and CEO Emerita of Global Liver Institute (GLI), which has helped shape and define the field of liver health across five continents. She has served on more than 30 boards and committees for universities, health systems, and government agencies, and has more published numerous peer-reviewed papers.
Articles by Donna R. Cryer, J.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
HHS Confirms Four Senior FDA Leaders, Including Agency's First-Ever AI Deputy Commissioner
2
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
3
Artisan Partners’ Director Calls for Novartis Board Shake-Up
4
How Elevated Cortisol Levels Can Impact Type II Diabetes Treatments
5